Inovio Drops 11% One Day After Soaring on Flu Vaccine Hopes

Despite today’s drop, shares of Inovio Pharmaceuticals, a developer of DNA-based vaccines against viruses and cancers, are up this week as the company publicized pre-clinical progress toward a universal flu vaccine.
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>